Onconetix Announces 1-for-10 Reverse Stock Split to Maintain Nasdaq Listing
ONCO is trading near its 52-week low of $0.306 (33% below the low) on elevated volume (3.5× avg).
Summary
Onconetix, Inc. announced a 1-for-10 reverse stock split, effective May 21, 2026, specifically to regain compliance with Nasdaq's minimum $1.00 bid price requirement. This action underscores the company's severe financial distress, following its recent Q1 2026 report which included a going concern warning, material weaknesses, and significant dilution from an equity line of credit. While the split aims to prevent delisting, it is generally viewed negatively by the market as it does not address the underlying operational or financial challenges. Traders will be watching if the split provides sustained compliance or if the stock continues its downward trend, potentially leading to further compliance issues.
At the time of this announcement, ONCO was trading at $0.21 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.5M. The 52-week trading range was $0.31 to $53.55. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.